James Vaughn

2016

In 2016, James Vaughn earned a total compensation of $1.6M as Chief Commercial Officer at Genomic Health, a 22% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$228,800
Option Awards$726,905
Salary$400,000
Stock Awards$284,850
Total$1,640,555

Vaughn received $726.9K in option awards, accounting for 44% of the total pay in 2016.

Vaughn also received $228.8K in non-equity incentive plan, $400K in salary and $284.9K in stock awards.

Rankings

In 2016, James Vaughn's compensation ranked 5,826th out of 14,075 executives tracked by ExecPay. In other words, Vaughn earned more than 58.6% of executives.

ClassificationRankingPercentile
All
5,826
out of 14,075
59th
Division
Services
1,015
out of 2,282
56th
Major group
Health Services
90
out of 209
57th
Industry group
Medical And Dental Laboratories
19
out of 61
69th
Industry
Medical Laboratories
19
out of 61
69th
Source: SEC filing on April 28, 2017.

Vaughn's colleagues

We found four more compensation records of executives who worked with James Vaughn at Genomic Health in 2016.

2016

Kimberly Popovits

Genomic Health

Chief Executive Officer

2016

G Cole

Genomic Health

Chief Financial Officer

2016

Frederic Pla

Genomic Health

Chief Business and Product Development Officer

2016

Steven Shak

Genomic Health

Chief Scientific Officer

News

You may also like